MedPath

fluticasone propionate and salmeterol

These highlights do not include all the information needed to use FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER safely and effectively. See full prescribing information for FLUTICASONE PROPIONATE AND SALMETEROL INHALATION POWDER. FLUTICASONE PROPIONATE and SALMETEROL inhalation powder, for oral inhalation use Initial U.S. Approval: 2000

Approved
Approval ID

ce347bf4-4cc1-46dc-b5f1-6f8ff48da84b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 28, 2022

Manufacturers
FDA

Teva Pharmaceuticals USA, Inc.

DUNS: 001627975

Products 3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

fluticasone propionate and salmeterol

PRODUCT DETAILS

NDC Product Code0093-7517
Application NumberANDA213948
Marketing CategoryC73584
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateSeptember 28, 2022
Generic Namefluticasone propionate and salmeterol

INGREDIENTS (2)

FLUTICASONE PROPIONATEActive
Quantity: 100 ug in 1 1
Code: O2GMZ0LF5W
Classification: ACTIB
SALMETEROL XINAFOATEActive
Quantity: 50 ug in 1 1
Code: 6EW8Q962A5
Classification: ACTIM

fluticasone propionate and salmeterol

PRODUCT DETAILS

NDC Product Code0093-7516
Application NumberANDA213948
Marketing CategoryC73584
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateSeptember 28, 2022
Generic Namefluticasone propionate and salmeterol

INGREDIENTS (2)

SALMETEROL XINAFOATEActive
Quantity: 50 ug in 1 1
Code: 6EW8Q962A5
Classification: ACTIM
FLUTICASONE PROPIONATEActive
Quantity: 500 ug in 1 1
Code: O2GMZ0LF5W
Classification: ACTIB

fluticasone propionate and salmeterol

PRODUCT DETAILS

NDC Product Code0093-7518
Application NumberANDA213948
Marketing CategoryC73584
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateSeptember 28, 2022
Generic Namefluticasone propionate and salmeterol

INGREDIENTS (2)

FLUTICASONE PROPIONATEActive
Quantity: 250 ug in 1 1
Code: O2GMZ0LF5W
Classification: ACTIB
SALMETEROL XINAFOATEActive
Quantity: 50 ug in 1 1
Code: 6EW8Q962A5
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

fluticasone propionate and salmeterol - FDA Drug Approval Details